Drugs / epoetin alfa or beta
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT00081484 Comparator | Jun 2004 → Mar 2006 | anemia | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 3 | NCT00077623 Comparator | Mar 2004 → Sep 2005 | anemia | Hoffmann-La Roche | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | epoetin alfa or beta | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00077623 ↗ |
| Route | Intravenous | “iv or sc, as prescribed” NCT00081484 ↗ |
| Route | Subcutaneous | “iv or sc, as prescribed” NCT00081484 ↗ |